Net profit of Bliss GVS Pharma declined 13.80% to Rs 23.80 crore in the quarter ended December 2024 as against Rs 27.61 crore during the previous quarter ended December 2023. Sales rose 4.83% to Rs 210.42 crore in the quarter ended December 2024 as against Rs 200.72 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 210.42 | 200.72 | 5 |
| OPM % | 14.15 | 21.77 | - |
| PBDT | 43.97 | 47.00 | -6 |
| PBT | 36.42 | 40.04 | -9 |
| NP | 23.80 | 27.61 | -14 |